Reckitt Benckiser Group Stock Beta
| RBGPF Stock | USD 61.00 0.04 0.07% |
Reckitt Benckiser Group fundamentals help investors to digest information that contributes to Reckitt Benckiser's financial success or failures. It also enables traders to predict the movement of Reckitt Pink Sheet. The fundamental analysis module provides a way to measure Reckitt Benckiser's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Reckitt Benckiser pink sheet.
Reckitt |
Reckitt Benckiser Group Company Beta Analysis
Reckitt Benckiser's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Reckitt Benckiser Beta | 0.17 |
Most of Reckitt Benckiser's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Reckitt Benckiser Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Reckitt Benckiser Group has a Beta of 0.1702. This is 86.16% lower than that of the Consumer Defensive sector and 86.16% lower than that of the Household & Personal Products industry. The beta for all United States stocks is notably lower than that of the firm.
Reckitt Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Reckitt Benckiser's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Reckitt Benckiser could also be used in its relative valuation, which is a method of valuing Reckitt Benckiser by comparing valuation metrics of similar companies.Reckitt Benckiser is currently under evaluation in beta category among its peers.
As returns on the market increase, Reckitt Benckiser's returns are expected to increase less than the market. However, during the bear market, the loss of holding Reckitt Benckiser is expected to be smaller as well.
Reckitt Fundamentals
| Return On Equity | 0.39 | |||
| Return On Asset | 0.0681 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 61.62 B | |||
| Shares Outstanding | 715.77 M | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 60.03 % | |||
| Price To Earning | 30.53 X | |||
| Price To Book | 4.62 X | |||
| Price To Sales | 3.75 X | |||
| Revenue | 13.23 B | |||
| Gross Profit | 7.69 B | |||
| EBITDA | 465 M | |||
| Net Income | (32 M) | |||
| Cash And Equivalents | 1.29 B | |||
| Cash Per Share | 1.80 X | |||
| Total Debt | 6.81 B | |||
| Debt To Equity | 1.10 % | |||
| Current Ratio | 0.70 X | |||
| Book Value Per Share | 12.47 X | |||
| Cash Flow From Operations | 1.7 B | |||
| Earnings Per Share | 5.15 X | |||
| Price To Earnings To Growth | 3.26 X | |||
| Target Price | 7400.0 | |||
| Number Of Employees | 40 K | |||
| Beta | 0.17 | |||
| Market Capitalization | 49.74 B | |||
| Total Asset | 26.95 B | |||
| Retained Earnings | 21.09 B | |||
| Working Capital | (2.59 B) | |||
| Current Asset | 3.48 B | |||
| Current Liabilities | 6.07 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 2.57 % | |||
| Net Asset | 26.95 B | |||
| Last Dividend Paid | 1.75 |
About Reckitt Benckiser Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Reckitt Benckiser Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reckitt Benckiser using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reckitt Benckiser Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Reckitt Pink Sheet
Reckitt Benckiser financial ratios help investors to determine whether Reckitt Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Reckitt with respect to the benefits of owning Reckitt Benckiser security.